CERA

unofficial impact factor 1.46

Open Access Research

Health and economic impact of combining metformin with nateglinide to achieve glycemic control: Comparison of the lifetime costs of complications in the U.K

Alexandra J Ward*, Maribel Salas, J Jaime Caro and David Owens

Cost Effectiveness and Resource Allocation 2004, 2:2 doi:10.1186/1478-7547-2-2

No comments have yet been made on this article.

Post a comment